These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 27133491)

  • 1. Patient-Reported Outcome Measures in Systemic Sclerosis (Scleroderma).
    Pellar RE; Tingey TM; Pope JE
    Rheum Dis Clin North Am; 2016 May; 42(2):301-16. PubMed ID: 27133491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a patient-reported outcome instrument for skin involvement in patients with systemic sclerosis.
    Man A; Correa JK; Ziemek J; Simms RW; Felson DT; Lafyatis R
    Ann Rheum Dis; 2017 Aug; 76(8):1374-1380. PubMed ID: 28213563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient participation in patient-reported outcome instrument development in systemic sclerosis.
    Pauling JD; Frech TM; Domsic RT; Hudson M
    Clin Exp Rheumatol; 2017; 35 Suppl 106(4):184-192. PubMed ID: 28516884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatigue and Its Association With Social Participation, Functioning, and Quality of Life in Systemic Sclerosis.
    Murphy SL; Kratz AL; Whibley D; Poole JL; Khanna D
    Arthritis Care Res (Hoboken); 2021 Mar; 73(3):415-422. PubMed ID: 31841268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of childhood scleroderma on physical function and quality of life.
    Baildam EM; Ennis H; Foster HE; Shaw L; Chieng AS; Kelly J; Herrick AL; Richards HL
    J Rheumatol; 2011 Jan; 38(1):167-73. PubMed ID: 21041272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of hand and face disabilities on global disability and quality of life in systemic sclerosis patients.
    Maddali-Bongi S; Del Rosso A; Mikhaylova S; Francini B; Branchi A; Baccini M; Matucci-Cerinic M
    Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-15-20. PubMed ID: 24850211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Italian version of the Systemic Sclerosis Questionnaire: a comparison of quality of life in patients with systemic sclerosis and with other connective tissue disorders.
    Uras C; Tabolli S; Giannantoni P; Rocco G; Abeni D
    G Ital Dermatol Venereol; 2014 Oct; 149(5):539-48. PubMed ID: 24975952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.
    Khanna D; Clements PJ; Furst DE; Chon Y; Elashoff R; Roth MD; Sterz MG; Chung J; FitzGerald JD; Seibold JR; Varga J; Theodore A; Wigley FM; Silver RM; Steen VD; Mayes MD; Connolly MK; Fessler BJ; Rothfield NF; Mubarak K; Molitor J; Tashkin DP;
    Arthritis Rheum; 2005 Feb; 52(2):592-600. PubMed ID: 15692967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Lipo-PGE1 on health-related quality of life in patients with systemic sclerosis and systemic lupus erythematosus in Japan.
    Hoshi K; Fukuhara S
    J Int Med Res; 2008; 36(1):187-97. PubMed ID: 18230278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can Routine Use of Patient-Reported Outcomes Help Guide Systemic Sclerosis Chronic Disease Care?
    Frech TM; Hess R; Biber J; Young J; Hardman A; Weeks H; Peterson KA; Scholand MB
    J Clin Rheumatol; 2018 Aug; 24(5):272-274. PubMed ID: 29509559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Social/economic costs and health-related quality of life in patients with scleroderma in Europe.
    López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Kanavos P; Taruscio D; Schieppati A; Iskrov G; Péntek M; Delgado C; von der Schulenburg JM; Persson U; Chevreul K; Fattore G;
    Eur J Health Econ; 2016 Apr; 17 Suppl 1():109-17. PubMed ID: 27038626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validity and responsiveness of the Michigan Hand Questionnaire in patients with systemic sclerosis.
    Schouffoer AA; van der Giesen FJ; Beaart-van de Voorde LJ; Wolterbeek R; Huizinga TW; Vliet Vlieland TP
    Rheumatology (Oxford); 2016 Aug; 55(8):1386-93. PubMed ID: 27074806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sexual activity and functioning in female scleroderma patients.
    Impens AJ; Rothman J; Schiopu E; Cole JC; Dang J; Gendrano N; Rosen RC; Seibold JR
    Clin Exp Rheumatol; 2009; 27(3 Suppl 54):38-43. PubMed ID: 19796560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease and symptom burden in systemic sclerosis: a patient perspective.
    Suarez-Almazor ME; Kallen MA; Roundtree AK; Mayes M
    J Rheumatol; 2007 Aug; 34(8):1718-26. PubMed ID: 17611983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Patient-centered assessment of functional health in systemic sclerosis -- where are we now?].
    Sigl T; Ewert T; Stucki G
    Z Rheumatol; 2004 Dec; 63(6):463-9. PubMed ID: 15605210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pain, fatigue and hand function closely correlated to work ability and employment status in systemic sclerosis.
    Sandqvist G; Scheja A; Hesselstrand R
    Rheumatology (Oxford); 2010 Sep; 49(9):1739-46. PubMed ID: 20511345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Participation in life situations by persons with systemic sclerosis.
    Poole JL; Chandrasekaran A; Hildebrand K; Skipper B
    Disabil Rehabil; 2015; 37(10):842-5. PubMed ID: 25052100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life and functional disability in patients with interstitial lung disease related to Systemic Sclerosis.
    Lumetti F; Barone L; Alfieri C; Silva M; Serra V; Delsante G; Sverzellati N; Ariani A
    Acta Biomed; 2015 Sep; 86(2):142-8. PubMed ID: 26422428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic sclerosis.
    Hughes M; Herrick AL
    Br J Hosp Med (Lond); 2019 Sep; 80(9):530-536. PubMed ID: 31498665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon.
    Merkel PA; Herlyn K; Martin RW; Anderson JJ; Mayes MD; Bell P; Korn JH; Simms RW; Csuka ME; Medsger TA; Rothfield NF; Ellman MH; Collier DH; Weinstein A; Furst DE; Jiménez SA; White B; Seibold JR; Wigley FM;
    Arthritis Rheum; 2002 Sep; 46(9):2410-20. PubMed ID: 12355489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.